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CD1a immunopositivity could help to
address prognosis of intestinal-type
Barrett’s metaplasia
Sir: I read with great interest the letter of Lopes et al.
that compared Alcian blue-periodic acid-Schiff stain
with immunohistochemistry for MUC-2 in 40 patients
with Barrett’s metaplasia (BM) of intestinal-type (IT).1
In their research, they found that ‘MUC-2 expression
turned out to be a helpful tool for the correct
identification of intestinal metaplasia, avoiding any
false-negative of even false-positive results’.
We agree with them that ‘an adequate diagnosis’ of
BM ‘is very important’ for the management of this
disease, but since ‘the incidence of adenocarcinoma in
this epithelium ranges between 0.2% and 2.1% in
patients without dysplasia and up to 70% in those with
high-grade dysplasia’, we consider of greater interest to
have a test that may help to predict the prognosis.
As the anti-tumoral role of CD1a was recently
postulated, we investigated its presence in metaplastic
epithelium of Barrett’s oesophagus, both gastric and IT.
CD1a is a surface glycoprotein of 49 kDa commonly
expressed by dendritic cells, cortical thymocytes and
Langerhans cells of skin and mucosa; moreover,
immunoexpression of CD1a is commonly researched
to differentiate various cutaneous lymphomas (T-cell)
from B-cell lymphomas and pseudolymphomas.
In a preliminary work on 113 biopsies of BM, we
reported that the most of cases (75%) of BM were
positive for CD1a;2 in particular, we were the first to
demonstrate that CD1a could be expressed by epithelial
cells, other that dendritic cells, in BM. Consequently,
we reported that the expression of CD1a by metaplastic
epithelial cells might help to distinguish BM by the
presence of heterotopic mucosa in the esophageal
wall.
Recently, we examined 65 patients with IT BM
and we found that 55 of them were positive for CD1a
(Figure 1A), while normal intestinal mucosa is always
negative (Figure 1B). Nevertheless, eight of 10 patients
that were negative for CD1a underwent dysplasia at
1–3 years follow-up. Dysplastic tissues were also neg-
ative for CD1a (Figure 1C). By contrast, IT BM diagnosis
was confirmed at follow-up of all 55 positive cases.
Our data already suggested that this marker might
help to predict the prognosis of this pathology in both
Figure 1. A, Immunohistochemistry for CD1a in IT BM shows this
marker localized above all in epithelial cells. B, Normal intestinal
mucosa does not express this protein. C, Dysplasia on IT BM does not
show any immunopositivity.
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gastric- and IT BM.2 In light of our recent experiments,
we feel it necessary to confirm this hypothesis.
In conclusion, although malignant transformation
may be a rare event, we suggest that CD1a could be a
new marker not only to distinguish heterotopic mucosa
from BM but also to predict the prognosis of this
condition.
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Low-grade intraepithelial neoplasia
of Brunner’s gland
Sir: Most Brunner’s gland tumours within the duode-
num, so called Brunner’s gland adenomas or brun-
neriomas, are not true neoplasms but represent
hyperplasias or hamartomas consisting of mature
mucus-producing glands.1 We would like to report
the very rare case of low-grade intraepithelial neoplasia
of Brunner’s gland.
A 69-year-old woman underwent esophago-gastro-
duodenoscpy because of suspected esophageal varices.
In the duodenum multiple small elevations of the
duodenal mucosa were found and duodenal biopsies
were taken.
Histological examination of the duodenal biopsies
revealed lobulated and hyperplastic Brunner’s glands
(Figure 1a) with a small focus of apparently neoplastic
Figure 1. Small focus of low-grade intraepithelial neoplasia of Brunner’s gland in conventional histology (a and b) and immunohistochemistry
with antibodies against MIB-1 (c) and p53 (d).
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